128 related articles for article (PubMed ID: 8669886)
21. Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.
Bièche I; Lidereau R
Mol Carcinog; 2000 Nov; 29(3):151-8. PubMed ID: 11108660
[TBL] [Abstract][Full Text] [Related]
22. Compartment switching of WNT-2 expression in human breast tumors.
Dale TC; Weber-Hall SJ; Smith K; Huguet EL; Jayatilake H; Gusterson BA; Shuttleworth G; O'Hare M; Harris AL
Cancer Res; 1996 Oct; 56(19):4320-3. PubMed ID: 8813115
[TBL] [Abstract][Full Text] [Related]
23. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase.
Zelinski DP; Zantek ND; Walker-Daniels J; Peters MA; Taparowsky EJ; Kinch MS
J Cell Biochem; 2002; 85(4):714-20. PubMed ID: 11968011
[TBL] [Abstract][Full Text] [Related]
25. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
26. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.
Silva JM; Domínguez G; González-Sancho JM; García JM; Silva J; García-Andrade C; Navarro A; Muñoz A; Bonilla F
Oncogene; 2002 Jun; 21(27):4307-16. PubMed ID: 12082618
[TBL] [Abstract][Full Text] [Related]
27. Involvement of Myc targets in c-myc and N-myc induced human tumors.
Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
29. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
30. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
31. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
[TBL] [Abstract][Full Text] [Related]
32. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival.
Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
Invasion Metastasis; 1996; 16(1):19-26. PubMed ID: 8830762
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor-alpha, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features.
Cericatto R; Pozzobon A; Morsch DM; Menke CH; Brum IS; Spritzer PM
Steroids; 2005 Mar; 70(3):153-60. PubMed ID: 15763593
[TBL] [Abstract][Full Text] [Related]
36. [Expression of estrogen sulfotransferase (EST) gene and bridging integrator protein-1 (BIN1) gene and their significance in breast tissues].
Deng WH; Wu YY; Yang L; Tang WQ; Wang S
Ai Zheng; 2004 Nov; 23(11):1302-5. PubMed ID: 15522178
[TBL] [Abstract][Full Text] [Related]
37. Stage-specific expression of breast cancer-specific gene gamma-synuclein.
Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205
[TBL] [Abstract][Full Text] [Related]
38. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
Yang Y
Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin.
Pavlidis N; Briassoulis E; Bai M; Fountzilas G; Agnantis N
Anticancer Res; 1995; 15(6B):2563-7. PubMed ID: 8669824
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Spandidos DA; Pintzas A; Kakkanas A; Yiagnisis M; Mahera H; Patra E; Agnantis NJ
Anticancer Res; 1987; 7(6):1299-304. PubMed ID: 3327455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
